Drug Shortage Report for PMS-ESTRADIOL
Report ID | 87227 |
Drug Identification Number | 02148595 |
Brand name | ESTRACE |
Common or Proper name | ESTRADIOL |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | ESTRADIOL |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G03CA |
ATC description | ESTROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-07-01 |
Actual start date | 2019-07-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-10-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-10-15 | French | Compare |
v8 | 2021-10-15 | English | Compare |
v7 | 2019-07-02 | French | Compare |
v6 | 2019-07-02 | English | Compare |
v5 | 2019-07-02 | English | Compare |
v4 | 2019-06-21 | French | Compare |
v3 | 2019-06-21 | English | Compare |
v2 | 2019-06-21 | French | Compare |
v1 | 2019-06-21 | English | Compare |
Showing 1 to 9 of 9